Aurobindo Pharma Buyback 2026 vs Puretrop Fruits Buyback 2026

Comparison between Aurobindo Pharma Buyback 2026 and Puretrop Fruits Buyback 2026.

Buyback Details

Aurobindo Pharma Buyback 2026 is a Tender Offer buyback proposed to list at BSE, NSE while Puretrop Fruits Buyback 2026 is a Tender Offer proposed to list at BSE.

 Aurobindo Pharma LtdPuretrop Fruits Ltd
LogoAurobindo Pharma Buyback 2026 LogoPuretrop Fruits Buyback 2026 Logo
Type of BuybackTender OfferTender Offer
Listing AtBSE, NSEBSE
Face Value₹10 per share₹10 per share
Buyback Price₹1475 per share₹200 per share
Issue Size54,23,728 shares11,00,000 shares
Issue Size (Amount)₹800.00 Crores₹22.00 Crores
Buyback Ratio
CategoryEntitlement RatioShares Offered
Small Shareholders7 : 618,13,560
General Category2 : 24946,10,168

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

CategoryEntitlement RatioShares Offered
Small Shareholders4 : 291,82,975
General Category4 : 299,17,025

Note:

  • Small Shareholders are retail shareholders under SEBI regulations.

  • General Category includes all other eligible shareholders.

  • Entitlement ratio is based on fully paid-up equity shares held on the record date.

RegistrarKfin Technologies Ltd.Bigshare Services Pvt.Ltd.
Lead ManagersAxis Capital Ltd.Vivro Financial Services Pvt.Ltd.
Necessity of the buyback

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:

  • Return surplus funds to shareholders and enhance overall shareholder returns.
  • Optimise the Company’s capital structure.
  • Improve financial ratios such as earnings per share and return on equity.
  • Enhance long-term shareholder value.
  • Provide shareholders the flexibility to either participate in the Buyback for cash or retain their shareholding and benefit from an increased post-buyback ownership.

Buyback Timetable

Aurobindo Pharma Buyback 2026 and Puretrop Fruits Buyback 2026 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Aurobindo Pharma Buyback 2026 Buyback record date is Apr 17, 2026. Puretrop Fruits Buyback 2026 Buyback record date is Apr 10, 2026.

 Aurobindo Pharma LtdPuretrop Fruits Ltd
Record DateApr 17, 2026Apr 10, 2026
Offer Open DateApr 23, 2026Apr 17, 2026
Offer Closure DateApr 29, 2026Apr 23, 2026
Last date for receipt of tender formsApr 29, 2026Apr 23, 2026
Finalisation of buybackMay 07, 2026Apr 29, 2026
Last Date for settlment of bidsMay 07, 2026Apr 30, 2026
Last Date for extinguishment of sharesMay 18, 2026May 12, 2026

Financial Details and Other Relevent Information

Comparison of Aurobindo Pharma Buyback 2026 and Puretrop Fruits Buyback 2026 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

 Aurobindo Pharma LtdPuretrop Fruits Ltd
Financial

Company Financials (Restated Consolidated)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets49,784.9745,071.5139,889.99
Total Income32,345.5829,559.2525,145.97
Profit After Tax1,582.721,211.02684.85
EBITDA6,605.005,843.003,758.00
NET Worth32,647.0029,851.00
Reserves and Surplus20,476.0319,664.2317,975.44
Amount in ₹ Crore

Company Financials (Restated)

Period Ended30 Sep 202531 Mar 202531 Mar 2024
Total Income56.48114.27109.29
Profit After Tax18.8411.8759.95
NET Worth126.29107.47138.79
Reserves and Surplus118.3299.50128.90
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.90 1180.00 1272.16
Feb-2026 1250.85 1106.25 1179.45
Jan-2026 1270.40 1115.80 1176.03

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2026 183.00 180.20 181.60
Jan-2026 183.95 150.85 167.40
Dec-2025 167.70 147.00 157.35
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Mar-2026 1330.00 1179.80 1272.09
Feb-2026 1250.90 1106.00 1179.10
Jan-2026 1270.80 1116.20 1175.87

Compare with others

Compare:

Aurobindo Pharma Buyback 2026 and Puretrop Fruits Buyback 2026